We recently compiled a list of the Jim Cramer’s 10 Go-To Stocks for Success. In this article, we are going to take a look at ...

The maker of blockbuster appetite-suppressing drugs Mounjaro and Zepbound is seeking to end a regulatory designation that has ...

Eli Lilly is cutting the cost of certain weight loss drugs, with new single-dose vials costing less than other medications ...

The GLP-1 drug giant’s shares have surged this year. Eli Lilly could keep climbing thanks to strong demand for Mounjaro and ...

The cheaper drug will compete with compounded versions of the same medication sold by digital health companies.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 626.12% and ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against Goldman Sachs' other ...

Eli Lilly is intensifying its efforts to combat imitation versions of its popular appetite-suppressing drugs, Mounjaro and ...

Eli Lilly may not be an expensive stock when you consider its long-run growth prospects.

We recently compiled a list of the 12 Best Dividend Stocks For Steady Growth. In this article, we are going to take a look at ...

International drugmaker, Eli Lilly, announced plans in May to invest $5.3 billion (€4.9 billion) in a new manufacturing site ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against Morgan Stanley’s other ...